Pfiz­er eyes po­ten­tial for co-ad­min­is­tra­tion of its new Pre­vnar 20 and the sea­son­al flu shot

Pfiz­er has joined the ranks of drug­mak­ers look­ing to com­bine sea­son­al vac­cines, re­veal­ing new da­ta on Wednes­day sug­gest­ing its fresh­ly ap­proved 20-va­lent pneu­mo­coc­cal vac­cine can …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER